- Home
- BCSF vs MDXG Comparison
BCSF vs MDXG Comparison
Compare BCSF & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCSF
- MDXG
- Stock Information
- Founded
- BCSF 2015
- MDXG 2006
- Country
- BCSF United States
- MDXG United States
- Employees
- BCSF N/A
- MDXG N/A
- Industry
- BCSF Finance/Investors Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- BCSF Finance
- MDXG Health Care
- Exchange
- BCSF Nasdaq
- MDXG Nasdaq
- Market Cap
- BCSF 983.4M
- MDXG 1.0B
- IPO Year
- BCSF 2018
- MDXG N/A
- Fundamental
- Price
- BCSF $13.41
- MDXG $7.05
- Analyst Decision
- BCSF Buy
- MDXG Buy
- Analyst Count
- BCSF 2
- MDXG 1
- Target Price
- BCSF $16.50
- MDXG $12.00
- AVG Volume (30 Days)
- BCSF 428.1K
- MDXG 699.9K
- Earning Date
- BCSF 11-04-2025
- MDXG 10-29-2025
- Dividend Yield
- BCSF 13.14%
- MDXG N/A
- EPS Growth
- BCSF N/A
- MDXG N/A
- EPS
- BCSF 1.66
- MDXG 0.21
- Revenue
- BCSF $283,687,000.00
- MDXG $363,774,000.00
- Revenue This Year
- BCSF N/A
- MDXG $12.68
- Revenue Next Year
- BCSF N/A
- MDXG $8.18
- P/E Ratio
- BCSF $8.24
- MDXG $33.71
- Revenue Growth
- BCSF N/A
- MDXG 6.85
- 52 Week Low
- BCSF $13.20
- MDXG $5.47
- 52 Week High
- BCSF $19.21
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- BCSF 23.38
- MDXG 50.36
- Support Level
- BCSF $13.62
- MDXG $6.62
- Resistance Level
- BCSF $14.37
- MDXG $7.35
- Average True Range (ATR)
- BCSF 0.31
- MDXG 0.22
- MACD
- BCSF -0.08
- MDXG 0.01
- Stochastic Oscillator
- BCSF 0.57
- MDXG 60.96
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.